William Ericson, Director, Ten Percent Owner at Adamas Pharmaceuticals, holds 18.80K shares in Pacific Biosciences (Ticker: PACB), holds 0.00 shares in Adamas Pharmaceuticals (Ticker: ADMS).

See the Hottest Stocks Based on Insider Trading >

William Ericson
Adamas Pharmaceuticals (ADMS)
Director, Ten Percent Owner

Ranked #14,295 out of 98,564 Corporate Insiders

Profitable Transactions

6 out of 11 Profitable Transactions

Average Return

+10.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

PACB

A breakdown of William Ericson's holdings

See the Top Stocks by Insiders

Insider Roles

Pacific Biosciences
(PACB)

Director

Roles that William Ericson holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Adamas Pharmaceuticals
(ADMS)

Rating:Informative Buy

Date:Sep 09, 2016 - Sep 09, 2017

Return:+44.70%

The most profitable trade made by William Ericson

See the Latest Stocks Traded by Insiders

William Ericson's Trading History

ADMS

Adamas Pharmaceuticals

Nov 24, 2021

―

Uninformative Sell

―

$0.00

PACB

Pacific Biosciences

Mar 17, 2023

Director

Uninformative Sell

67.11K

$27.63K

List of latest transactions for each holding click on a transaction to see William Ericson's performance on stock

See All Insider Trading from Today

William Ericson insider profile FAQ

What is the percentage of profitable transactions made by William Ericson?

The percentage of profitable transactions made by William Ericson is 55%.

What is the average return per transaction made by William Ericson?

The average return per transaction made by William Ericson is 10.90%.

What stocks does William Ericson hold?

William Ericson holds: ADMS, PACB stocks.

What was William Ericson’s latest transaction?

William Ericson latest transaction was an Uninformative Sell of $67.11K.

What was William Ericson's most profitable transaction?

William Ericson’s most profitable transaction was an Informative Buy of ADMS stock on September 9, 2016. The return on the trade was 44.70%.

What is William Ericson's role in Adamas Pharmaceuticals?

William Ericson's role in Adamas Pharmaceuticals is Director, Ten Percent Owner.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

William Ericson Insider Profile

William Ericson Adamas Pharmaceuticals (ADMS)Director, Ten Percent Owner